Motivational intervention for teens at risk of alcohol and cannabis use

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This intervention focuses on providing a brief motivational interviewing approach to address alcohol and cannabis use among diverse adolescents aged 12-17. Teens who screen positive for risky substance use will be enrolled through partner clinics, where they will complete an online consent process and baseline survey. Based on their responses, participants will receive either enhanced usual care or the Chat intervention, which can be delivered virtually or in-person. Follow-up surveys will be conducted at 3, 6, and 12 months, with participants receiving gift card incentives for their participation.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* receive health care at one of two participating health systems
* aged 12-17
* screen positive for being at risk for alcohol or cannabis use using the CRAFFT

Exclusion Criteria:

* if they don't meet the inclusion criteria, they will be excluded

Where it's running

• AltaMed Health Services
  Commerce, California, United States Recruiting
• Valley Community Healthcare
  North Hollywood, California, United States Recruiting
• University of Pittsburgh Medical Center Children's Hospital
  Pittsburgh, Pennsylvania, United States Recruiting

Study contacts

• Principal investigator: Elizabeth J. D'Amico, PhD — Rand
• Study coordinator: Elizabeth J D'Amico, PhD
• Email: damico@rand.org
• Phone: 3103930411

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• vEAET-H: a virtual group emotional therapy for chronic pain patients using medical cannabis in Israel

  This study tests a Hebrew, virtual, group-based emotional therapy to see if it can help reduce pain and improve emotional well-being in Israeli adults with chronic musculoskeletal pain who use medical cannabis.

  Recruiting Reuth Rehabilitation Hospital · Tel Aviv · NCT07732062

• Testing warning labels on cannabis packaging to see what design helps people notice risks

  Researchers are testing different cannabis warning labels to see which designs make people notice health risks and think about their use more carefully.

  Recruiting University of Oklahoma · Oklahoma City, Oklahoma · NCT07701304

• Mobile app to help adults in Quebec use cannabis more safely

  A mobile app is being tested to see if it helps adults who use cannabis non-medically in Quebec use cannabis more safely.

  Recruiting Centre hospitalier de l'Université de Montréal (CHUM) · Montreal, Quebec · NCT07524985

• Feasibility of a perinatal smoking and cannabis cessation program

  This study tests a perinatal program to help pregnant people quit tobacco and cannabis and stay smoke-free after birth.

  Recruiting University of Pittsburgh · Pittsburgh, Pennsylvania · NCT07489443

• Psychiatric Symptoms in Methamphetamine Psychosis With or Without Lifetime Cannabis Use

  This study tests whether lifetime cannabis use changes the course and severity of psychiatric symptoms in people hospitalized with methamphetamine-induced psychosis.

  Recruiting Elazığ Mental Health and Diseases Hospital · Elâzığ, Elâzığ and 1 other locations · NCT07459270

• Cannabis use and IV sedation during wisdom tooth removal

  This project will see if people who use cannabis need different IV sedative doses or have different vital signs and breathing during wisdom tooth removal compared with people who don't use cannabis.

  Recruiting University of Michigan · Ann Arbor, Michigan · NCT07423195

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.